Search for Articles:
Title / Keyword
Author / Affiliation / Email
Journal
Article Type
 
 
Advanced Search
 
Section
Special Issue
Volume
Issue
Number
Page
 
7.7
4.2
Journals
Microorganisms
Special Issues
Gut Microbiota, Diet, and Gastrointestinal Cancer, 2nd Edition
share announcement

Gut Microbiota, Diet, and Gastrointestinal Cancer, 2nd Edition

A special issue of Microorganisms (ISSN 2076-2607). This special issue belongs to the section "Gut Microbiota".

Deadline for manuscript submissions: 30 November 2025 | Viewed by 481

Special Issue Editors

Dr. Flavio De Maio

E-Mail
Guest Editor
Fondazione Policlinico Universitario Agostino Gemelli IRCCS, Rome, Italy
Interests: gut microbiota; intestinal microbiome
Special Issues, Collections and Topics in MDPI journals
Dr. Marco Cintoni

E-Mail Website
Guest Editor
1. UOC Nutrizione Clinica, Fondazione Policlinico Agostino Gemelli IRCCS, 00168 Rome, Italy
2. Centro di Ricerca e Formazione in Nutrizione Umana, Università Cattolica del Sacro Cuore, 00168 Rome, Italy
Interests: clinical nutrition; nutritional prehabilitation; nutrition in oncology; nutrition during radiotherapy; perioperative nutrition; body composition
Special Issues, Collections and Topics in MDPI journals

Special Issue Information

Dear Colleagues,

This Special Issue of Microorganisms is a continuation of our 2025 Special Issue titled "Gut Microbiota, Diet, and Gastrointestinal Cancer". Welcome to the second edition of this Special Issue.

The link between the gut microbiota (GM) and gastrointestinal neoplasms is two-way. On the one hand, GM influences the development of neoplasms through the proinflammatory modulation of the local microenvironment; on the other hand, it is influenced by the neoplastic cells themselves and by the various treatments (chemotherapy, radiotherapy, surgery, etc.) to which patients are subjected. GM is influenced by prebiotic, probiotic, and postbiotic supplementation, but the best way to modulate it is through dietary patterns.

More thoroughly understanding the type of relationship between nutrition, GM, and gastrointestinal cancers could lead to the development of new treatments and the improvement of supportive therapies along the oncological pathway.

We invite you to submit perspective papers, original papers, narrative reviews, and systematic reviews, as well as meta-analyses related to this Special Issue.

Dr. Flavio De Maio
Dr. Marco Cintoni
Guest Editors

Manuscript Submission Information

Manuscripts should be submitted online at www.mdpi.com by registering and logging in to this website. Once you are registered, click here to go to the submission form. Manuscripts can be submitted until the deadline. All submissions that pass pre-check are peer-reviewed. Accepted papers will be published continuously in the journal (as soon as accepted) and will be listed together on the special issue website. Research articles, review articles as well as short communications are invited. For planned papers, a title and short abstract (about 100 words) can be sent to the Editorial Office for announcement on this website.

Submitted manuscripts should not have been published previously, nor be under consideration for publication elsewhere (except conference proceedings papers). All manuscripts are thoroughly refereed through a single-blind peer-review process. A guide for authors and other relevant information for submission of manuscripts is available on the Instructions for Authors page. Microorganisms is an international peer-reviewed open access monthly journal published by MDPI.

Please visit the Instructions for Authors page before submitting a manuscript. The Article Processing Charge (APC) for publication in this open access journal is 2700 CHF (Swiss Francs). Submitted papers should be well formatted and use good English. Authors may use MDPI's English editing service prior to publication or during author revisions.

Keywords

  • gut microbiota
  • diet
  • nutrition
  • gastrointestinal cancer
  • colorectal cancer
  • probiotics
  • prebiotics
  • postbiotics
  • radiotherapy
  • chemotherapy

Benefits of Publishing in a Special Issue

  • Ease of navigation: Grouping papers by topic helps scholars navigate broad scope journals more efficiently.
  • Greater discoverability: Special Issues support the reach and impact of scientific research. Articles in Special Issues are more discoverable and cited more frequently.
  • Expansion of research network: Special Issues facilitate connections among authors, fostering scientific collaborations.
  • External promotion: Articles in Special Issues are often promoted through the journal's social media, increasing their visibility.
  • Reprint: MDPI Books provides the opportunity to republish successful Special Issues in book format, both online and in print.

Further information on MDPI's Special Issue policies can be found here.

Published Papers (1 paper)

Order results
Result details
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:

Review

23 pages, 378 KB  
Review
Optimizing Nutritional Balance: Integrating the Mediterranean Diet into Low-FODMAP Nutrition
by Athanasia Dimitriou, Ioanna Aggeletopoulou and Christos Triantos
Microorganisms 2025, 13(9), 2085; https://doi.org/10.3390/microorganisms13092085 - 7 Sep 2025
Viewed by 264
Abstract
Irritable Bowel Syndrome (IBS) is a functional disorder of the digestive system. Its global prevalence varies widely, estimated at up to 10%, due to differences in diagnostic criteria, cultural factors, and dietary patterns. Dietary interventions have emerged as first-line strategies for symptom management, [...] Read more.
Irritable Bowel Syndrome (IBS) is a functional disorder of the digestive system. Its global prevalence varies widely, estimated at up to 10%, due to differences in diagnostic criteria, cultural factors, and dietary patterns. Dietary interventions have emerged as first-line strategies for symptom management, with the low-FODMAP (fermentable oligo-, di-, and monosaccharide and polyol) diet demonstrating robust efficacy in reducing gastrointestinal symptoms by minimizing poorly absorbed, fermentable carbohydrates. However, concerns regarding the long-term nutritional adequacy, potential alterations in gut microbiota composition, and sustainability of the low-FODMAP diet have prompted the need for more integrative and nutritionally balanced dietary models. In contrast, the Mediterranean Diet (MD), rich in fruits, vegetables, legumes, whole grains, nuts, olive oil, and omega-3 fatty acids from fish, is widely recognized for its anti-inflammatory, cardiometabolic, and potential anticarcinogenic effects. Notably, adherence to the MD has been associated with favorable gut microbial profiles and reduced risk of colorectal and other gastrointestinal cancers. However, the high FODMAP content of many MD components limits its immediate compatibility with IBS dietary protocols. This review explores the evidence supporting the integration of MD principles into a low-FODMAP framework for the dietary management of IBS. Rather than proposing a new model, we synthesize existing literature, including recent clinical findings, and offer practical, evidence-informed guidance for tailoring a Mediterranean-style low-FODMAP diet that supports both symptom management and long-term nutritional health. Integrating MD principles into the low-FODMAP approach offers a promising strategy to enhance the nutritional quality, sustainability, and long-term efficacy of dietary management in IBS. Full article
(This article belongs to the Special Issue Gut Microbiota, Diet, and Gastrointestinal Cancer, 2nd Edition)
Show export options expand_more Show export options expand_less
Select all
Export citation of selected articles as:
 
Displaying articles 1-1
Back to TopTop